Biomedical Textiles Global Market Report 2024

The global biomedical textiles market has grown strongly in recent years. It will grow from $15.63 billion in 2023 to $16.74 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth observed in the historical period can be attributed to several key factors. Firstly, there was a heightened prioritization of infection control, reflecting a global emphasis on healthcare measures to manage and prevent infectious diseases. Global health emergencies further underscored the importance of healthcare solutions and infrastructure, contributing to growth. The increased focus on regenerative medicine, which involves advanced therapies to repair or replace damaged tissues, played a role in the overall expansion of the biomedical textiles sector. Additionally, the prevalence of chronic diseases fueled the demand for innovative medical textiles to address the evolving healthcare landscape.

The global biomedical textiles market is expected to see strong growth in the next few years. It will grow to $23.1 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period can be attributed to various factors. Firstly, consumer health and wellness trends are expected to drive demand for innovative biomedical textiles. The increasing emphasis on global health preparedness, prompted by ongoing health challenges, is likely to contribute to the growth of the sector. Military and defense applications, along with the evolving needs of personalized medicine, are anticipated to fuel demand for specialized biomedical textiles. The rise of telemedicine and wearable health technologies is expected to further drive market expansion. Major trends expected in the forecast period include ongoing advancements in medical technology, fostering the development of cutting-edge biomedical textiles. Increased research collaborations are anticipated to drive innovation and expand the application areas of these textiles. Furthermore, there is a growing trend towards sustainable textiles, aligning with broader sustainability initiatives in the healthcare sector. These trends reflect the dynamic nature of the biomedical textiles industry and its responsiveness to evolving healthcare needs and technological advancements.

The biomedical textiles market is witnessing growth driven by the escalating prevalence of chronic diseases, which demand prolonged medical attention and surgical interventions. Biomedical textiles play a crucial role in chronic disease management, aiding wound closure during surgeries and preventing chronic wounds. A projection from The Silver Book, developed by The Alliance for Aging Research, estimates a 42% increase in chronic disease cases, reaching 230.7 million globally by 2030. This surge in chronic conditions is anticipated to be a significant driver for the biomedical textiles market.

The biomedical textiles market is set for expansion due to the rising global healthcare expenditure. Increased spending on healthcare goods and services, including advanced medical treatments and technologies, directly impacts the demand for specialized biomedical textile materials. A report from the UK's Office for National Statistics reveals that healthcare spending in the UK surged by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021. Notably, investments in preventive care doubled to $45.72 billion in 2021. The upward trajectory in healthcare expenditures is a pivotal factor driving the growth of the biomedical textiles market.

In the biomedical textiles market, product innovations emerge as a key trend, with major industry players focusing on research and development to introduce cutting-edge solutions. In March 2022, Fabiosys Innovations launched Fabium, a medical textile utilizing Hi-PAT technology for enhanced efficacy against viruses, bacteria, and fungi. This innovation involves processing raw cotton fabric with proprietary chemical formulas through standard textile equipment. The pursuit of novel products through innovation remains a cornerstone in shaping the dynamics of the biomedical textiles market.

Major companies operating in the biomedical textiles sector are strategically collaborating to introduce smart textile platforms that revolutionize the development of biomedical textiles. These partnerships enable the integration of medicine, wellness, and health benefits into clothing, leveraging the combined expertise of the collaborating entities. In August 2023, Nufabrx partnered with Enventys Partners to launch HealthWear, a groundbreaking smart-textile platform that seamlessly administers topical medications activated by body heat and moisture. This strategic collaboration exemplifies the industry's drive to enhance biomedical textiles through innovative solutions.

Strategic acquisitions are bolstering companies' positions in the biomedical textiles market. In April 2022, Integer acquired Aran Biomedical for $131 million. This acquisition enables Integer to integrate Aran Biomedical's technological expertise and knowledge in biomaterial-focused medical implant products with its industry-leading production scale and delivery methods. Aran Biomedical, based in Ireland, contributes to the advancement of biomedical textiles in the context of medical implant products.

Major companies operating in the biomedical textiles market report are Koninklijke DSM N.V., Confluent Medical Technologies, Cardinal Health Inc., Johnson & Johnson Services Inc., B. Braun Melsungen AG, Smith & Nephew PLC, Meister & Ice AG, Medline Industries Inc., 3M Company, ATEX Technologies, Integra Life Sciences Corporation, Paul Hartmann AG, BSN Medical GMBH, Elkem ASA, Bally Ribbon Mills, Asahi Kasei Corporation, Freudenberg Medical LLC, Getinge AB, Halyard Health, Kimberly-Clark Corporation, Milliken & Company, Molnlycke Health Care AB, Precision Fabrics Group Inc., Secant Group LLC, Stradis Healthcare, Tietex International Ltd., Trelleborg AB, United Medical Industries Co. Ltd., Vestagen Protective Technologies Inc., W.L. Gore & Associates Inc., Weaving Machinery UK Ltd., Welspun Group, and Zimmer Biomet Holdings.

North America was the largest region in the biomedical textiles market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomedical textiles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biomedical textiles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary product types within biomedical textiles include non-implantable and implantable categories. Non-implantable biomedical textiles are employed for external wound dressings. These substances are applied externally to the body, potentially coming into contact with the skin. They are manufactured using various fabrics, such as non-woven biomedical textiles, woven biomedical textiles, and knitted biomedical textiles, and can be composed of non-biodegradable or biodegradable fibers. Applications span across ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery and treatment, and other medical fields. Biomedical textiles find utilization in hospitals, ambulatory centers, clinics, community healthcare, and other end-user settings.

This report provides biomedical textiles market statistics, including biomedical textiles industry global market size, regional shares, competitors with a biomedical textiles market share, detailed biomedical textiles market segments, market trends and opportunities, and any further data you may need to thrive in the biomedical textiles industry. This biomedical textiles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomedical textiles market consists of sales of textiles for sutures & ligatures, vascular implants, soft tissue implants, hard tissue implants and hernia repair. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.